Pharmagen Inc. (OTCMKTS:PHRX) Stock Short Interest Report for September

Pharmagen Inc. (OTCMKTS:PHRX) was the target of a large increase in short interest in September. As of September 30th, there was short interest totaling 7,400 shares. Based on an average trading volume of 1,000 shares, the days-to-cover ratio is presently 7.4 days.

Pharmagen Stock Performance

Pharmagen has a 1-year low of $0.00 and a 1-year high of $0.00.

Pharmagen Company Profile

Pharmagen, Inc distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes.